DAGLA

diacylglycerol lipase alpha, the group of Lipases

Basic information

Region (hg38): 11:61680391-61747001

Previous symbols: [ "C11orf11" ]

Links

ENSG00000134780NCBI:747OMIM:614015HGNC:1165Uniprot:Q9Y4D2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Neuroocular syndrome 2, paroxysmal typeADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic35737950

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DAGLA gene.

  • Inborn_genetic_diseases (84 variants)
  • not_provided (33 variants)
  • DAGLA-related_disorder (18 variants)
  • Benign_paroxysmal_tonic_upgaze_of_childhood_with_ataxia (7 variants)
  • Autism (1 variants)
  • Autosomal_dominant_cerebellar_ataxia (1 variants)
  • not_specified (1 variants)
  • Attention_deficit_hyperactivity_disorder (1 variants)
  • See_cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DAGLA gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006133.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
17
clinvar
3
clinvar
20
missense
96
clinvar
10
clinvar
2
clinvar
108
nonsense
3
clinvar
1
clinvar
2
clinvar
6
start loss
0
frameshift
2
clinvar
1
clinvar
5
clinvar
8
splice donor/acceptor (+/-2bp)
3
clinvar
3
Total 5 2 106 27 5
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DAGLAprotein_codingprotein_codingENST00000257215 1966569
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.0000105125735071257420.0000278
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense4.014027000.5740.00004946687
Missense in Polyphen136328.410.414123149
Synonymous-0.09203173151.010.00002372217
Loss of Function5.83345.40.06600.00000213505

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.00005470.0000544
Finnish0.000.00
European (Non-Finnish)0.00004510.0000439
Middle Eastern0.00005470.0000544
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the hydrolysis of diacylglycerol (DAG) to 2- arachidonoyl-glycerol (2-AG), the most abundant endocannabinoid in tissues. Required for axonal growth during development and for retrograde synaptic signaling at mature synapses. {ECO:0000269|PubMed:14610053}.;
Pathway
Aldosterone synthesis and secretion - Homo sapiens (human);Retrograde endocannabinoid signaling - Homo sapiens (human);Cell-type Dependent Selectivity of CCK2R Signaling;Cannabinoid receptor signaling;Signaling by GPCR;Signal Transduction;Effects of PIP2 hydrolysis;Platelet activation, signaling and aggregation;Arachidonate production from DAG;Hemostasis;G alpha (q) signalling events;GPCR downstream signalling;N-cadherin signaling events (Consensus)

Recessive Scores

pRec
0.120

Intolerance Scores

loftool
0.141
rvis_EVS
-0.57
rvis_percentile_EVS
18.96

Haploinsufficiency Scores

pHI
0.393
hipred
Y
hipred_score
0.655
ghis
0.546

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.369

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Dagla
Phenotype
normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
dagla
Affected structure
retinal ganglion cell
Phenotype tag
abnormal
Phenotype quality
hypoplastic

Gene ontology

Biological process
G protein-coupled glutamate receptor signaling pathway;neuroblast proliferation;arachidonic acid metabolic process;neurogenesis;neurotransmitter biosynthetic process;diacylglycerol catabolic process;endocannabinoid signaling pathway;retrograde trans-synaptic signaling by endocannabinoid
Cellular component
plasma membrane;varicosity;postsynaptic membrane;integral component of postsynaptic membrane
Molecular function
metal ion binding;acylglycerol lipase activity